Healthcare Touched New Lows: Recro Pharma (NASDAQ:REPH), Sophiris Bio (NASDAQ:SPHS), LipoScience Inc (NASDAQ:LPDX), Mediwound Ltd (NASDAQ:MDWD)

Recro Pharma, Inc. (NASDAQ:REPH), a clinical stage specialty pharmaceutical company developing non-opioid therapeutics for post-operative pain, today announced the appointments of Alfred F. Altomari and Dr. Michael Berelowitz to the Company’s Board of Directors. Recro Pharma Inc (NASDAQ:REPH) stock performance was 1.95% in last session and finished the day at $7.32. Traded volume was 35,553.00million shares in the last session and the average volume of … Continue reading Healthcare Touched New Lows: Recro Pharma (NASDAQ:REPH), Sophiris Bio (NASDAQ:SPHS), LipoScience Inc (NASDAQ:LPDX), Mediwound Ltd (NASDAQ:MDWD)

Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) announced the closing of its initial public offering of 3,263,010 ordinary shares at a public offering price of $13.50 per share, which included 425,610 ordinary shares issued upon the exercise in full of the underwriters’ option to purchase additional ordinary shares to cover over-allotments. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) stock performance was -1.58% in last session and finished the day at $10.93. … Continue reading Biotech New Lows: Galmed Pharmaceuticals (NASDAQ:GLMD), Recro Pharma (NASDAQ:REPH), BioTime (NYSEMKT:BTX), Onconova Therapeutics (NASDAQ:ONTX)

China Biologic Products, Inc. (NASDAQ:CBPO), a leading fully integrated plasma-based biopharmaceutical company in China , today announced its financial results for the fourth quarter and fiscal year 2013. China Biologic Products Inc (NASDAQ:CBPO) stock performance was -6.25% in last session and finished the day at $32.85. Traded volume was 32,311.00million shares in the last session and the average volume of the stock remained 21.68K shares. … Continue reading Biotech Losers: China Biologic Products (NASDAQ:CBPO), Heat Biologics (NASDAQ:HTBX), Recro Pharma Inc (NASDAQ:REPH), Egalet Corp (NASDAQ:EGLT)

Sinovac Biotech Ltd (NASDAQ:SVA) a leading biopharmaceutical company in China has reported its fourth quarter and full year unaudited results for the period ending December 31, 2013. Sinovac Biotech Ltd. (NASDAQ:SVA) stock performance was 17.13% in last session and finished the day at $8.07. Traded volume was 4,876,818 million shares in the last session and the average volume of the stock remained 342.45 million shares. … Continue reading Biotech New Highs: Sinovac Biotech (NASDAQ:SVA), Neuralstem (NYSEMKT:CUR), Durata Therapeutics Inc (NASDAQ:DRTX), Recro Pharma (NASDAQ:REPH)

Facebook Inc. (NASDAQ:FB), which closed its acquisition of mobile messaging service WhatsApp on Monday, has no near-term plan to make money from the service, Chief Executive Mark Zuckerberg said on Thursday. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 23.70% and weekly performance is -5.85%. On last trading day company shares ended up $72.91. Facebook Inc (NASDAQ:FB) distance from 50-day simple … Continue reading Stocks in Focus : Facebook Inc (NASDAQ:FB), Micron Technology, Inc. (NASDAQ:MU), Can-Fite BioPharma Ltd. (NYSEMKT:CANF), Recro Pharma, Inc. (NASDAQ:REPH), Excel Trust (NYSE:EXL)

Nabors Industries (NYSE:NBR) has been given a “BBB-” credit rating by Morningstar. The credit rating agency’s “BBB-” rating suggests that the company is a moderate default risk. They also issued a negative credit outlook for the company and gave their stock a three star rating. Nabors Industries Ltd. (NYSE:NBR) belongs to Basic Materials sector. Its net profit margin is 2.40% and weekly performance is 0.12%. … Continue reading Today’s Watch List : Nabors Industries (NYSE:NBR), Wells Fargo & Company (NYSE:WFC), Progenics Pharmaceuticals (NASDAQ:PGNX), Recro Pharma (NASDAQ:REPH), Masco Corporation (NYSE:MAS),